Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

September 20, 2021

Treatment of occipital neuralgia using onabotulinum toxin A.

Acta Neurologica Scandinavica
Isabela Maria Garcia MarcollaHélio A Ghizoni Teive
September 20, 2021
Open Access

Therapeutic Effects of Intra-articular Botulinum Neurotoxin Versus Physical Therapy in Knee Osteoarthritis.

Anesthesiology and Pain Medicine
Zahra RezasoltaniReza Kazempour Mofrad
September 20, 2021

Forehead Movement Discrepancies After Botulinum Toxin Injections: A Review of Etiology, Correction, and Prevention.

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]
Bridget WalkerCameron Chesnut
September 20, 2021

Middle ear myoclonus: Systematic review of results and complications for various treatment approaches.

American Journal of Otolaryngology
Wai Keat Wong, Michael Fook-Ho Lee
September 17, 2021

A Single-Blinded Prospective Study on Using Botulinum Toxin Type A for Reducing Alar Mobility.

Aesthetic Surgery Journal
Yehong ZhongZheyuan Yu
September 17, 2021

Botulinum Toxin A in the Management of a Gummy Smile: A Clinical Controlled Preliminary Study.

Aesthetic Surgery Journal
Aline Bitencourt CostaKaren Müller Ramalho
September 16, 2021
Open Access

Isolation and characterization of a highly specific monoclonal antibody targeting the botulinum neurotoxin type E exposed SNAP-25 neoepitope

BioRxiv : the Preprint Server for Biology
A. MechalyOhad Mazor
September 16, 2021

[Botox preceding ventral hernia repair: it's not about esthetics].

Nederlands tijdschrift voor geneeskunde
Allard S TimmerMarja A Boermeester
September 16, 2021

Gummy Smile Management Using Diode Laser Gingivectomy Versus Botulinum Toxin Injection - A Prospective Study.

Annals of Maxillofacial Surgery
Aida M MossaadShadia Abdel-Hameed Elsayed
September 15, 2021

Role of botulinum toxin A in improving facial erythema and skin quality.

Archives of Dermatological Research
Edith HannaVince Bertucci
September 14, 2021

Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications.

Advances in Therapy
Warner W CarrJ Wesley Sublett
September 14, 2021

A Case of Parotid Gland Fistula After Microtia Reconstruction Successfully Treated With Botulinum Toxin Type A.

Ear, Nose, & Throat Journal
Bo ZhangAnqi Fu
September 10, 2021

Mild Botulism From Illicitly Brewed Alcohol in a Large Prison Outbreak in Mississippi.

Frontiers in Public Health
Mariel MarlowKevin Chatham-Stephens
September 10, 2021
Open Access

Novel Lytic Enzyme of Prophage Origin from Clostridium botulinum E3 Strain Alaska E43 with Bactericidal Activity against Clostridial Cells.

International Journal of Molecular Sciences
Agnieszka MorzywolekTadeusz Kaczorowski

Sign up to follow this feed and discover related papers.

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Ascariasis (ASM)

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

© 2021 Meta ULC. All rights reserved